検索結果

Quality Policies | About Senju | SENJU Pharmaceutical

e carry out all activities according to the following policies: （Realization of products） · We seek evidence-based, world-class, and high-quality products across the entire production process from R&a...

Product Development Policy | Research & Development | SENJU Pharmaceutica

e (4.65 million people in Japan) and is expected to increase in the future #7, 8. The only reliable evidence-based treatment is a decrease of ocular pressure. Treatment options include drug therapy (e...

sual impairment, resulting in less than 0.1 in decimal visual acuity 1) . However, no guidelines or evidence-based therapies have been established in the world for CRAO2) . Senju will work diligently ...

sual impairment, resulting in less than 0.1 in decimal visual acuity(1) . However, no guidelines or evidence-based therapies have been established anywhere in the world for CRAO(2) . Senju will work d...

sual impairment, resulting in less than 0.1 in decimal visual acuity 1) . However, no guidelines or evidence-based therapies have been established in the world for CRAO2) . Senju will work diligently ...